Gene Expression and Transcriptome Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

1 Market Overview
1.1 Gene Expression and Transcriptome Sequencing Product Introduction
1.2 Global Gene Expression and Transcriptome Sequencing Market Size Forecast
1.3 Gene Expression and Transcriptome Sequencing Market Trends & Drivers
1.3.1 Gene Expression and Transcriptome Sequencing Industry Trends
1.3.2 Gene Expression and Transcriptome Sequencing Market Drivers & Opportunity
1.3.3 Gene Expression and Transcriptome Sequencing Market Challenges
1.3.4 Gene Expression and Transcriptome Sequencing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gene Expression and Transcriptome Sequencing Players Revenue Ranking (2023)
2.2 Global Gene Expression and Transcriptome Sequencing Revenue by Company (2019-2024)
2.3 Key Companies Gene Expression and Transcriptome Sequencing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Gene Expression and Transcriptome Sequencing Product Offered
2.5 Key Companies Time to Begin Mass Production of Gene Expression and Transcriptome Sequencing
2.6 Gene Expression and Transcriptome Sequencing Market Competitive Analysis
2.6.1 Gene Expression and Transcriptome Sequencing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Gene Expression and Transcriptome Sequencing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Expression and Transcriptome Sequencing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Gene Expression
3.1.2 Transcriptome Sequencing
3.2 Global Gene Expression and Transcriptome Sequencing Sales Value by Type
3.2.1 Global Gene Expression and Transcriptome Sequencing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Gene Expression and Transcriptome Sequencing Sales Value, by Type (2019-2030)
3.2.3 Global Gene Expression and Transcriptome Sequencing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biotechnology
4.1.2 Academic Research and Government Institutes
4.1.3 Hospitals and Diagnostic Centers
4.2 Global Gene Expression and Transcriptome Sequencing Sales Value by Application
4.2.1 Global Gene Expression and Transcriptome Sequencing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Gene Expression and Transcriptome Sequencing Sales Value, by Application (2019-2030)
4.2.3 Global Gene Expression and Transcriptome Sequencing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Gene Expression and Transcriptome Sequencing Sales Value by Region
5.1.1 Global Gene Expression and Transcriptome Sequencing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Gene Expression and Transcriptome Sequencing Sales Value by Region (2019-2024)
5.1.3 Global Gene Expression and Transcriptome Sequencing Sales Value by Region (2025-2030)
5.1.4 Global Gene Expression and Transcriptome Sequencing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
5.2.2 North America Gene Expression and Transcriptome Sequencing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
5.3.2 Europe Gene Expression and Transcriptome Sequencing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
5.4.2 Asia Pacific Gene Expression and Transcriptome Sequencing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
5.5.2 South America Gene Expression and Transcriptome Sequencing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
5.6.2 Middle East & Africa Gene Expression and Transcriptome Sequencing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gene Expression and Transcriptome Sequencing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Gene Expression and Transcriptome Sequencing Sales Value
6.3 United States
6.3.1 United States Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
6.3.2 United States Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Gene Expression and Transcriptome Sequencing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
6.4.2 Europe Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Gene Expression and Transcriptome Sequencing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
6.5.2 China Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Gene Expression and Transcriptome Sequencing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
6.6.2 Japan Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Gene Expression and Transcriptome Sequencing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
6.7.2 South Korea Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Gene Expression and Transcriptome Sequencing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
6.8.2 Southeast Asia Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Gene Expression and Transcriptome Sequencing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Gene Expression and Transcriptome Sequencing Sales Value, 2019-2030
6.9.2 India Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Gene Expression and Transcriptome Sequencing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Gene Expression and Transcriptome Sequencing Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Gene Expression and Transcriptome Sequencing Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Illumina
7.2.1 Illumina Profile
7.2.2 Illumina Main Business
7.2.3 Illumina Gene Expression and Transcriptome Sequencing Products, Services and Solutions
7.2.4 Illumina Gene Expression and Transcriptome Sequencing Revenue (US$ Million) & (2019-2024)
7.2.5 Illumina Recent Developments
7.3 QIAGEN (Exiqon)
7.3.1 QIAGEN (Exiqon) Profile
7.3.2 QIAGEN (Exiqon) Main Business
7.3.3 QIAGEN (Exiqon) Gene Expression and Transcriptome Sequencing Products, Services and Solutions
7.3.4 QIAGEN (Exiqon) Gene Expression and Transcriptome Sequencing Revenue (US$ Million) & (2019-2024)
7.3.5 Agilent Technologies Recent Developments
7.4 Agilent Technologies
7.4.1 Agilent Technologies Profile
7.4.2 Agilent Technologies Main Business
7.4.3 Agilent Technologies Gene Expression and Transcriptome Sequencing Products, Services and Solutions
7.4.4 Agilent Technologies Gene Expression and Transcriptome Sequencing Revenue (US$ Million) & (2019-2024)
7.4.5 Agilent Technologies Recent Developments
7.5 Roche
7.5.1 Roche Profile
7.5.2 Roche Main Business
7.5.3 Roche Gene Expression and Transcriptome Sequencing Products, Services and Solutions
7.5.4 Roche Gene Expression and Transcriptome Sequencing Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Recent Developments
7.6 GE Healthcare
7.6.1 GE Healthcare Profile
7.6.2 GE Healthcare Main Business
7.6.3 GE Healthcare Gene Expression and Transcriptome Sequencing Products, Services and Solutions
7.6.4 GE Healthcare Gene Expression and Transcriptome Sequencing Revenue (US$ Million) & (2019-2024)
7.6.5 GE Healthcare Recent Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Profile
7.7.2 Bio-Rad Laboratories Main Business
7.7.3 Bio-Rad Laboratories Gene Expression and Transcriptome Sequencing Products, Services and Solutions
7.7.4 Bio-Rad Laboratories Gene Expression and Transcriptome Sequencing Revenue (US$ Million) & (2019-2024)
7.7.5 Bio-Rad Laboratories Recent Developments
7.8 Fluidigm
7.8.1 Fluidigm Profile
7.8.2 Fluidigm Main Business
7.8.3 Fluidigm Gene Expression and Transcriptome Sequencing Products, Services and Solutions
7.8.4 Fluidigm Gene Expression and Transcriptome Sequencing Revenue (US$ Million) & (2019-2024)
7.8.5 Fluidigm Recent Developments
8 Industry Chain Analysis
8.1 Gene Expression and Transcriptome Sequencing Industrial Chain
8.2 Gene Expression and Transcriptome Sequencing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Gene Expression and Transcriptome Sequencing Sales Model
8.5.2 Sales Channel
8.5.3 Gene Expression and Transcriptome Sequencing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Gene Expression and Transcriptome Sequencing Market Trends
Table 2. Gene Expression and Transcriptome Sequencing Market Drivers & Opportunity
Table 3. Gene Expression and Transcriptome Sequencing Market Challenges
Table 4. Gene Expression and Transcriptome Sequencing Market Restraints
Table 5. Global Gene Expression and Transcriptome Sequencing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Gene Expression and Transcriptome Sequencing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Gene Expression and Transcriptome Sequencing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Gene Expression and Transcriptome Sequencing Product Type
Table 9. Key Companies Time to Begin Mass Production of Gene Expression and Transcriptome Sequencing
Table 10. Global Gene Expression and Transcriptome Sequencing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Expression and Transcriptome Sequencing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Gene Expression and Transcriptome Sequencing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Gene Expression and Transcriptome Sequencing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Gene Expression and Transcriptome Sequencing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Gene Expression and Transcriptome Sequencing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Gene Expression and Transcriptome Sequencing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Gene Expression and Transcriptome Sequencing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Gene Expression and Transcriptome Sequencing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Gene Expression and Transcriptome Sequencing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Gene Expression and Transcriptome Sequencing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Gene Expression and Transcriptome Sequencing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Gene Expression and Transcriptome Sequencing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Gene Expression and Transcriptome Sequencing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Gene Expression and Transcriptome Sequencing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Gene Expression and Transcriptome Sequencing Sales Value by Region (2019-2024) & (%)
Table 27. Global Gene Expression and Transcriptome Sequencing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Gene Expression and Transcriptome Sequencing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Gene Expression and Transcriptome Sequencing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Gene Expression and Transcriptome Sequencing Sales Value, (2025-2030) & (US$ Million)
Table 31. Thermo Fisher Scientific Basic Information List
Table 32. Thermo Fisher Scientific Description and Business Overview
Table 33. Thermo Fisher Scientific Gene Expression and Transcriptome Sequencing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Gene Expression and Transcriptome Sequencing Business of Thermo Fisher Scientific (2019-2024)
Table 35. Thermo Fisher Scientific Recent Developments
Table 36. Illumina Basic Information List
Table 37. Illumina Description and Business Overview
Table 38. Illumina Gene Expression and Transcriptome Sequencing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Gene Expression and Transcriptome Sequencing Business of Illumina (2019-2024)
Table 40. Illumina Recent Developments
Table 41. QIAGEN (Exiqon) Basic Information List
Table 42. QIAGEN (Exiqon) Description and Business Overview
Table 43. QIAGEN (Exiqon) Gene Expression and Transcriptome Sequencing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Gene Expression and Transcriptome Sequencing Business of QIAGEN (Exiqon) (2019-2024)
Table 45. QIAGEN (Exiqon) Recent Developments
Table 46. Agilent Technologies Basic Information List
Table 47. Agilent Technologies Description and Business Overview
Table 48. Agilent Technologies Gene Expression and Transcriptome Sequencing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Gene Expression and Transcriptome Sequencing Business of Agilent Technologies (2019-2024)
Table 50. Agilent Technologies Recent Developments
Table 51. Roche Basic Information List
Table 52. Roche Description and Business Overview
Table 53. Roche Gene Expression and Transcriptome Sequencing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Gene Expression and Transcriptome Sequencing Business of Roche (2019-2024)
Table 55. Roche Recent Developments
Table 56. GE Healthcare Basic Information List
Table 57. GE Healthcare Description and Business Overview
Table 58. GE Healthcare Gene Expression and Transcriptome Sequencing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Gene Expression and Transcriptome Sequencing Business of GE Healthcare (2019-2024)
Table 60. GE Healthcare Recent Developments
Table 61. Bio-Rad Laboratories Basic Information List
Table 62. Bio-Rad Laboratories Description and Business Overview
Table 63. Bio-Rad Laboratories Gene Expression and Transcriptome Sequencing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Gene Expression and Transcriptome Sequencing Business of Bio-Rad Laboratories (2019-2024)
Table 65. Bio-Rad Laboratories Recent Developments
Table 66. Fluidigm Basic Information List
Table 67. Fluidigm Description and Business Overview
Table 68. Fluidigm Gene Expression and Transcriptome Sequencing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Gene Expression and Transcriptome Sequencing Business of Fluidigm (2019-2024)
Table 70. Fluidigm Recent Developments
Table 71. Key Raw Materials Lists
Table 72. Raw Materials Key Suppliers Lists
Table 73. Gene Expression and Transcriptome Sequencing Downstream Customers
Table 74. Gene Expression and Transcriptome Sequencing Distributors List
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Gene Expression and Transcriptome Sequencing Product Picture
Figure 2. Global Gene Expression and Transcriptome Sequencing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Gene Expression and Transcriptome Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 4. Gene Expression and Transcriptome Sequencing Report Years Considered
Figure 5. Global Gene Expression and Transcriptome Sequencing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gene Expression and Transcriptome Sequencing Revenue in 2023
Figure 7. Gene Expression and Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Gene Expression Picture
Figure 9. Transcriptome Sequencing Picture
Figure 10. Global Gene Expression and Transcriptome Sequencing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Gene Expression and Transcriptome Sequencing Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Pharmaceutical and Biotechnology
Figure 13. Product Picture of Academic Research and Government Institutes
Figure 14. Product Picture of Hospitals and Diagnostic Centers
Figure 15. Global Gene Expression and Transcriptome Sequencing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Gene Expression and Transcriptome Sequencing Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Gene Expression and Transcriptome Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Gene Expression and Transcriptome Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Gene Expression and Transcriptome Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Gene Expression and Transcriptome Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Gene Expression and Transcriptome Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Gene Expression and Transcriptome Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Gene Expression and Transcriptome Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Gene Expression and Transcriptome Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Gene Expression and Transcriptome Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Gene Expression and Transcriptome Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Gene Expression and Transcriptome Sequencing Sales Value (%), (2019-2030)
Figure 28. United States Gene Expression and Transcriptome Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Gene Expression and Transcriptome Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Gene Expression and Transcriptome Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Gene Expression and Transcriptome Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 34. China Gene Expression and Transcriptome Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 36. China Gene Expression and Transcriptome Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Gene Expression and Transcriptome Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Gene Expression and Transcriptome Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Gene Expression and Transcriptome Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Gene Expression and Transcriptome Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Gene Expression and Transcriptome Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Gene Expression and Transcriptome Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 46. India Gene Expression and Transcriptome Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Gene Expression and Transcriptome Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 48. India Gene Expression and Transcriptome Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 49. Gene Expression and Transcriptome Sequencing Industrial Chain
Figure 50. Gene Expression and Transcriptome Sequencing Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation

Your Name

Your E-mail

Your message

Submit